The Wright Center for Community Health Earns National Recognition

The Wright Center for Community Health has been recognized by the American Heart Association (AHA) and the American Medical Association (AMA) for its commitment to improving patients’ blood pressure control rates, earning Gold Plus-level recognition as part of Target: BP.

Target: BP is a national initiative created by the AHA and AMA in response to the high prevalence of uncontrolled blood pressure. The highest award, Gold Plus, recognizes health care enterprises that have demonstrated evidence-based practices for blood pressure measurement and treatment, and in which high blood pressure is controlled in 70% or more of the affected adult patients.

The Wright Center also received two other Gold Awards from the AHA: one for improving the quality of care for patients with type 2 diabetes and cardiovascular risk factors through the Target: Type 2 Diabetes program; and the other for improving the quality of care through awareness, detection, and management of high cholesterol with evidence-based strategies and tools through the program, Check. Change. Control. Cholesterol.

Target: Type 2 Diabetes addresses heart disease and stroke risk factors in patients with Type 2 diabetes and puts the unparalleled expertise of the AHA to work for health care organizations nationwide, helping ensure the care provided to patients is aligned with the latest evidence- and research-based guidelines. Check. Change. Control. Cholesterol supports physicians and care teams by offering access to the latest research, tools, and resources to reach and sustain cholesterol control rates among the adult patient population they serve.

“Receiving these three Gold Awards from the American Heart Association and the American Medical Association underscores our commitment to advancing the health and well-being of patients living with these chronic conditions,” said Dr. Erin McFadden, chief medical officer at The Wright Center for Community Health. “Through timely diagnosis and evidence-based treatment, high blood pressure, high cholesterol, and type 2 diabetes can be effectively managed, empowering patients to achieve healthier, longer lives.”

Nearly half of all adults in the U.S. – about 122.4 million – are living with high blood pressure, also known as hypertension, according to the AHA. About 29.3 million U.S. adults have been diagnosed with diabetes, and another estimated 9.7 million are living with undiagnosed diabetes, the AHA said. Approximately 104 million adults in the United States (about 40%) have high cholesterol, according to the Centers for Disease Control and Prevention.

All three chronic illnesses increase a person’s risk for serious health complications, including cardiovascular disease and stroke, which are the No. 1 and No. 5 causes of death in the U.S., respectively. Stroke is a leading cause of disability, according to a 2025 report from the AHA.

“Cardiovascular disease is the leading cause of death for people living with Type 2 diabetes,” said Dr. Howard Haft, a member of the American Heart Association’s National Quality Oversight Committee. “Organizations that participate in programs like this help raise awareness of the link between diabetes and cardiovascular disease and can improve patient outcomes. We are pleased to recognize The Wright Center for its commitment to quality care.”

In fiscal year 2024-25, The Wright Center served about 38,300 unique patients at its growing network of community health centers in Lackawanna, Luzerne, Wayne, and Wyoming counties. As a nonprofit Federally Qualified Health Center Look-Alike and safety-net provider, it serves vulnerable and medically underserved populations, regardless of age, ethnic background, ZIP code, insurance status, or ability to pay. It accepts all insurance plans and offers a sliding-fee discount program based on federal poverty guidelines that considers family size and income. No patient is ever turned away due to an inability to pay. For more information, go to TheWrightCenter.org or call 570-209-0019.

The American Heart Association Encourages Participation in National Wear Red Day

Wear Red Day is approaching fast. While we won’t have our traditional Red Dress Pins, bracelets and paper hearts this year, we are still encouraging and supporting companies and the community to support our mission by Wearing Red and spreading awareness about heart disease in women. 

How can you participate?!?

Take pictures! Lots of pictures! And post the on social media using #nepaheartwalk
Need fun ideas on how to support in a virtual world?

  • Turn your Zoom background Red and take a picture of the group while on a conference call.
  • Start your meetings with a Heart fact. Need inspiration, find more information on www.heart.org. 
  • Walking meetings! Why chat in your seat when you can take your meeting to the hallways….get those steps in!
  • For those of you who are in the office, conduct a dress down day. Or a camera off Zoom day!

Due to the pandemic, we are handling donations a little differently this year.

  • Have cash? Can it be converted into a check or an online donation?
  • Checks should be made out the AMERICAN HEART ASSOCIATION and mailed to the address below. Please indicate on a note enclosed that this money is for a Wear Red Day fundraiser in Northeast PA.

American Heart Association
P.O. Box 3049
Syracuse, NY 13202

Geisinger Recognized by American Heart Association

Geisinger has been recognized by the American Heart Association (AHA) and American Medical Association (AMA) for commitment to helping improve blood pressure and cholesterol control rates among adult patients.

Through participation in the AHA and AMA’s Target BP™ initiative, Geisinger has earned Gold-level recognition. The Gold award recognizes health care organizations that have 70 percent or more of their adult patient population with high blood pressure controlled.

Geisinger has also earned Gold-level recognition through participation in the AHA’s Check. Change. Control. Cholesterol™ initiative. The Gold award recognizes health care organizations that have 70 percent or more of their adult patient population at risk for atherosclerotic cardiovascular disease (ASCVD) appropriately managed with statin therapy.

“Our Primary Care teams are profoundly dedicated to preventing, identifying and treating chronic conditions. Their work around management of these conditions, such as high blood pressure and high cholesterol, is a testament to their practice and the patients they serve,” said Stacei Faust, quality program coordinator for Geisinger Care Gaps. “It’s an honor to be recognized for that work by the AHA and AMA, and my pleasure to work alongside these remarkable colleagues.”

Hypertension (high blood pressure) is a leading risk factor for heart attacks, strokes and preventable death in the United States. There are 116 million U.S. adults living with high blood pressure, and less than half of those people have it under control – making diagnosing and effectively managing hypertension critical.

Cardiovascular disease remains a leading cause of morbidity and mortality in the U.S., with an estimated 92.1 million adults having at least one type of cardiovascular disease that can lead to heart attack, stroke or death. The use of statin therapy for the prevention of ASCVD in many higher-risk patients is supported by an extensive body of evidence, but many patients who might benefit from this therapy go untreated or undertreated, according to the AHA.

“We recognize how important aggressive and early treatment of chronic conditions like hypertension and hyperlipidemia is in preventing disease progression and serious complications like heart attack, stroke and kidney disease,” said Cybele Pacheco, M.D., director of Community Medicine in Geisinger’s west region. “Prevention and team-based management of chronic diseases is our focus in Primary Care, and it shows the collaborative work among our Geisinger teams.”